Nektar Therapeutics is a biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. Nektar also partners with the top biopharmaceutical companies to bring new products to market. To date, Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.The staff at Nektar Therapeutics come from unusually diverse demographic backgrounds. The company is 48.6% female and 52.4% ethnic minorities. Despite its diversity in other areas, Nektar Therapeutics employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 86.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party. Nektar Therapeutics has great employee retention with staff members usually staying with the company for 3.5 years.The average employee at Nektar Therapeutics makes $83,561 per year. In comparison, some of its highest paying competitors, like Novartis, Amgen, and Merck, pay $112,479, $93,349, and $90,328, respectively.Based in San Francisco, CA, Nektar Therapeutics is a medium-sized pharmaceutical company with 718 employees and a revenue of $98.4M.
Nektar Therapeutics's Mission Statement
We are focused on creating novel therapies aimed at selectively modulating the immune system to advance the treatment of cancer, autoimmune disorders and chronic inflammatory conditions.
For less than a Netflix subscription, get a new job.
5.0/5
Nektar Therapeutics employee reviews
Based on 1 ratings
Do you work at Nektar Therapeutics?
Help job seekers learn about working at Nektar Therapeutics
The founders of Nektar Therapeutics is John Patton.
The key people at Nektar Therapeutics are Howard W. Robin and John Patton.
Key People
Howard W. Robin
John Patton
The Inside Scoop
Nektar Therapeutics, founded in 1990, is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines. Their drugs are used for the treatments of cancer, auto-immune disease and chronic pain. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. The company employs a team of about 500 dedicated scientists, clinicians and employees that discover medicines for patients with debilitating diseases.
Nektar Therapeutics Rankings
Nektar Therapeutics is ranked #57 on the Best Pharmaceutical Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
The average a Nektar Therapeutics salary in the United States is $83,561 per year.
Nektar Therapeutics employees in the top 10 percent can make over $132,000 per year,
while Nektar Therapeutics employees at the bottom 10 percent earn less than $52,000 per year.
Average Nektar Therapeutics Salary
$83,561
yearly
$40.17 hourly
Updated March 14, 2024
Evaluate Nektar Therapeutics' commitment to diversity and inclusion.
Nektar Therapeutics diversity
9.7
Diversity Score
We calculated Nektar Therapeutics’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Nektar Therapeutics’s workforce.
Nektar Therapeutics diversity summary. Zippia estimates Nektar Therapeutics's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Nektar Therapeutics's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Nektar Therapeutics's workforce.
Nektar Therapeutics has 718 employees.
49% of Nektar Therapeutics employees are women, while 51% are men.
The most common ethnicity at Nektar Therapeutics is White (48%).
18% of Nektar Therapeutics employees are Asian.
18% of Nektar Therapeutics employees are Hispanic or Latino.
The average employee at Nektar Therapeutics makes $83,561 per year.
Nektar Therapeutics employees are most likely to be members of the democratic party.
Employees at Nektar Therapeutics stay with the company for 3.5 years on average.
Do you work at Nektar Therapeutics?
Did Nektar Therapeutics' compensation package meet your expectations?
Nektar Therapeutics Financial Performance
9.2
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Nektar Therapeutics currently has 92.1M in revenue. Nektar Therapeutics's most recent quarter produced 20.5m (q2'2023).
Nektar Therapeutics annual revenue
$1B
$955M
$716M
$477M
$239M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Highest paying Nektar Therapeutics competitors
Compare Nektar Therapeutics salaries to competitors, including Novartis, Amgen, and Merck. Employees at Novartis earn the highest average yearly salary of $112,479. The salaries at Amgen average $93,349 per year, and the salaries at Merck come in at $90,328 per year.
Zippia gives an in-depth look into the details of Nektar Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Nektar Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Nektar Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Nektar Therapeutics. The data presented on this page does not represent the view of Nektar Therapeutics and its employees or that of Zippia.
Nektar Therapeutics may also be known as or be related to Inhale Therapeutic Systems, Inc., NEKTAR THERAPEUTICS, Nektar, Nektar Therapeutics and Nektar Therapeutics Inc.